TerminatedNot applicableNCT02512692

Gemcitabine-Cisplatin-90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma

Studying Cholangiocarcinoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Medical University of South Carolina
Principal Investigator
Samuel L. Cooper, MD
Medical University of South Carolina
Intervention
SIR-Spheres microspheres (Yttrium-90 Microspheres)(device)
Enrollment
6 enrolled
Eligibility
18 years · All sexes
Timeline
20152021

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02512692 on ClinicalTrials.gov

Other trials for Cholangiocarcinoma

Additional recruiting or active studies for the same condition.

See all trials for Cholangiocarcinoma

← Back to all trials